Lung cancer screening: the way forward

被引：48

作者：

Field, J. K. ^{[1
]}

Duffy, S. W. ^{[2
]}

机构：

[1] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Dept Surg & Oncol, Liverpool L3 9TA, Merseyside, England

[2] Wolfson Inst Prevent Med, Ctr Epidemiol Math & Stat, Canc Res UK, London EC1M 6BQ, England

来源：

BRITISH JOURNAL OF CANCER | 2008年 / 99卷 / 04期

关键词：

lung cancer; screening; chest X-ray; CT screening; cost-effectiveness; risk modelling;

D O I：

10.1038/sj.bjc.6604509

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To take lung cancer screening into national programmes, we first have to answer the question whether low-dose computed tomography (LDCT) screening and treatment of early lesions will decrease lung cancer mortality compared with a control group, to accurately estimate the balance of benefits and harms, and to determine the cost-effectiveness of the intervention.

引用

页码：557 / 562

页数：6

共 49 条

[21]

INFANTE M, 2007, LUNG CANC

[22]

Kubík AK, 2000, CANCER, V89, P2363, DOI 10.1002/1097-0142(20001201)89:11+<2363::AID-CNCR9>3.3.CO

[23]

2-N

[24] Screening for lung cancer using low dose CT scanning [J].